Strong evidence supports the use of AI-powered portable MRI for stroke detection in multiple clinical settings, including the emergency department.
Data presented at the annual American Society of Neuroimaging meeting supports clinical value and broad utility of the portable Swoop(R) system in outpatient neurology. GUILFORD, Conn.--(BUSINESS WIRE ...
Christus Mother Frances Hospital in Tyler recently made a breakthrough on Jan. 16 by becoming the first in the United States ...
The Swoop portable MRI system showed 92% agreement with traditional MRI scans and was four times more likely to be chosen by ...
Please provide your email address to receive an email when new articles are posted on . The portable MRI detected a high percentage of stroke-related infarct. Hyperfine has “practical advantages” over ...
Atlantic Health Morristown Medical Center recently announced it is one of the first hospitals in the U.S. to use Hyperfine‘s next-generation AI-powered, portable magnetic resonance imaging system. The ...
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI ...
JACKSONVILLE, Fla. (Ivanhoe Newswire) - Whether it’s the brain, spine, joints, tissues, or organs, 10 million people will get an MRI or magnetic resonance imaging. It’s a diagnostic imaging procedure ...
(Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain--the Swoop (R) system--today ...
Healthcare Asia Magazine on MSN
Limited imaging infrastructure drives MRI growth in India
The country accounted for 22% of the Asia–Pacific MRI market in 2025. India’s magnetic resonance imaging (MRI) market is ...
New dementia study actively enrolling and new data to be presented at the 2025 Alzheimer's Association International Conference. GUILFORD, Conn.--(BUSINESS WIRE)-- Hyperfine, Inc. (HYPR) (Nasdaq: HYPR ...
Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results